Unique Ingredient Identifier 3K9958V90M is listed as a ingredient substance
| RN | 64-17-5 |
| EC | 200-578-6 |
| NCIT | C2190 |
| RXCUI | 448 |
| MF | C2H6O |
| INCHI KEY | LFQSCWFLJHTTHZ-UHFFFAOYSA-N |
| SMILES | CCO |
UNII 3K9958V90M ALCOHOL is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| DENTAL | SOLUTION | 11.6 % |
| EXTRACORPOREAL | SOLUTION | 5 % |
| IM - IV | INJECTABLE | 10 % |
| IM - IV | INJECTION | 20 % |
| IM - IV | SOLUTION, INJECTION | 10 % |
| IM - IV - SC | INJECTION | 6.1 % |
| INHALATION | AEROSOL, METERED | 95.89 % |
| INHALATION | AEROSOL, SPRAY | 33 % |
| INHALATION | SOLUTION | 25 % |
| INTRACAVITARY | INJECTION | NA |
| INTRAMUSCULAR | INJECTION | 12 %V/V |
| INTRAMUSCULAR | INJECTION, SOLUTION | 6.1 % |
| INTRAMUSCULAR | LIQUID | 10 %W/V |
| INTRAMUSCULAR | SOLUTION, INJECTION | 10 %W/V |
| INTRAVENOUS | INJECTABLE | 34.5 % |
| INTRAVENOUS | INJECTION | 92 % |
| INTRAVENOUS | INJECTION, EMULSION | 28.5 MG/1ML |
| INTRAVENOUS | INJECTION, SOLUTION | 6.1 % |
| INTRAVENOUS | LIQUID | 10 % |
| INTRAVENOUS | SOLUTION, CONCENTRATE | 39.46 % |
| INTRAVENOUS | SOLUTION, INJECTION | 391 mg/1mL |
| INTRAVENOUS | SOLUTION, INJECTION | 39.5 % |
| INTRAVENOUS INFUSION | INJECTION | 23 %V/V |
| INTRAVENOUS INFUSION | SOLUTION, INJECTION | 395 mg/mL |
| INTRAVESICAL | SOLUTION | 50 % |
| IV - SC | INJECTION | 0.95 % |
| IV(INFUSION) | INJECTION | 49 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.027 % |
| IV(INFUSION) | SOLUTION, INJECTION | 49.7 % |
| NASAL | AEROSOL | 2 % |
| NASAL | AEROSOL, METERED | 0.7 % |
| OPHTHALMIC | SOLUTION | 1.4 % |
| ORAL | SOLUTION | 356.3 MG/ML |
| ORAL | SOLUTION | 79 mg/1mL |
| ORAL | SOLUTION | 71.25 MG/5ML |
| ORAL | SOLUTION | 0.05 ML/ML |
| ORAL | SYRUP | 290 MG/5 ML |
| ORAL | SYRUP | 0.25 mL/5mL |
| ORAL | TABLET | 315 MG |
| PHOTOPHERESIS | SOLUTION | 5 % |
| RECTAL | GEL | 22.45 % |
| RECTAL | SUSPENSION | 0.35 % |
| RESPIRATORY (INHALATION) | AEROSOL, METERED | 10 % |
| RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | 0.081 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 6.1 % |
| SUBLINGUAL | SPRAY | 4.96 % |
| SUBLINGUAL | SPRAY, METERED | 0.95 % |
| SUBLINGUAL | TABLET | 0.001 MG |
| TOPICAL | AEROSOL, SPRAY | 10.3 %W/W |
| TOPICAL | CLOTH | 57.62 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | 60.43 %W/W |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | GEL | 94.78 %W/W |
| TOPICAL | LOTION | 11.79 %W/W |
| TOPICAL | PATCH | NA |
| TOPICAL | POWDER, FOR SOLUTION | NA |
| TOPICAL | SHAMPOO | 10.28 %W/V |
| TOPICAL | SOLUTION | 91.26 %W/W |
| TOPICAL | SOLUTION | 35 %V/V |
| TOPICAL | SOLUTION | 27.65 %W/V |
| TOPICAL | SOLUTION, LIQUID | 25 %W/W |
| TOPICAL | SPRAY | 49.3 %W/W |
| TOPICAL | SWAB | 30 %W/V |
| TRANSDERMAL | FILM, CONTROLLED RELEASE | 358.7 MG |
| TRANSDERMAL | GEL | 74.1 % |
| TRANSDERMAL | GEL | 65.8 %W/W |
| TRANSDERMAL | GEL, METERED | 73.5 % |
| TRANSDERMAL | PATCH, CONTROLLED RELEASE | NA |
| TRANSDERMAL | SOLUTION | 60.25 % |
| TRANSDERMAL | SPRAY | 90 %W/V |
| INHALATION | AEROSOL | 1 ug |
| INTRAVENOUS | INJECTION | 0.2 mL/1mL |
| ORAL | LIQUID | 75 mg/10mL |
| TOPICAL | AEROSOL, FOAM | 60 %W/W |
| TOPICAL | SOLUTION | 28.42 %W/W |
| IM - IV | INJECTION | 10 % |
| TOPICAL | AEROSOL | 68.5 %W/W |
| TOPICAL | POWDER, FOR SOLUTION | 40 %W/W |
| TOPICAL | SHAMPOO | 10 %W/W |